Table 2.
Anthropometric and metabolic characteristics of the patients with PCOS in total, non-hyperuricemia group and hyperuricemia group.
| Items | Total | Non-hyperuricemia | Hyperuricemia | p values |
|---|---|---|---|---|
| N = 199 | N = 142 (71.36%) | N = 57 (28.64%) | ||
| Age (years) | 28.04 ± 4.91 | 28.00 ± 4.80 | 28.14 ± 5.20 | 0.856 |
| Weight (kg) | 85.79 ± 24.06 | 81.14 ± 24.17 | 97.38 ± 19.60 | <0.001 |
| BMI (kg/m2) | 31.83 ± 8.31 | 30.26 ± 8.42 | 35.75 ± 6.62 | <0.001 |
| WC (cm) | 100.56 ± 19.03 | 96.88 ± 19.55 | 109.99 ± 13.83 | 0.088* |
| HC (cm) | 109.57 ± 14.35 | 107.11 ± 14.36 | 116.00 ± 12.31 | 0.814* |
| WHR | 0.91 ± 0.08 | 0.90 ± 0.08 | 0.95 ± 0.07 | 0.040* |
| SBP (mmHg) | 126.35 ± 14.79 | 123.73 ± 13.02 | 132.02 ± 16.83 | 0.076* |
| DBP (mmHg) | 81.85 ± 10.91 | 80.86 ± 10.14 | 83.98 ± 12.27 | 0.322* |
| FPG (mmol/L) | 5.57 ± 1.60 | 5.44 ± 1.58 | 5.88 ± 1.63 | 0.932* |
| PPG (mmol/L) | 8.38 ± 3.51 | 8.12 ± 3.62 | 9.00 ± 3.19 | 0.864* |
| FINS (mU/L) | 25.00 ± 19.18 | 21.48 ± 16.93 | 33.50 ± 21.68 | 0.075* |
| F-CP (mmol/L) | 3.94 ± 1.60 | 3.63 ± 1.60 | 4.61 ± 1.40 | 0.093* |
| HbA1c (%) | 5.78 ± 1.04 | 5.72 ± 1.01 | 5.92 ± 1.09 | 0.800* |
| HOMA-IR | 6.55 ± 5.89 | 5.55 ± 5.40 | 8.95 ± 6.36 | 0.161* |
| ALT (U/L) | 43.47 ± 41.80 | 36.97 ± 38.09 | 59.33 ± 46.35 | 0.063* |
| AST (U/L) | 29.52 ± 25.10 | 26.43 ± 21.55 | 37.12 ± 31.15 | 0.193* |
| TC (mmol/L) | 4.65 ± 0.88 | 4.57 ± 0.77 | 4.86 ± 1.09 | 0.013* |
| TG (mmol/L) | 1.62 ± 1.21 | 1.46 ± 1.15 | 2.01 ± 1.26 | 0.068* |
| LDL-c (mmol/L) | 2.83 ± 0.79 | 2.76 ± 0.68 | 3.01 ± 0.98 | 0.041* |
| HDL-c (mmol/L) | 1.22 ± 0.39 | 1.28 ± 0.41 | 1.07 ± 0.26 | 0.061* |
| Cr (μmol/L) | 58.44 ± 8.55 | 58.36 ± 8.31 | 58.64 ± 9.19 | 0.218* |
The data are presented as the mean ± standard deviation.
*p-values represented the results after adjustment for BMI.
The bold values indicate statistical significance.
BMI, body mass index; WC, waist circumference; HC, hip circumference; WHR, waist/hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; PPG, postprandial plasma glucose; FINS, fasting insulin; F-CP, fasting C peptide; HbA1c, glycosylated hemoglobin A1c; HOMA-IR, homeostasis model assessment of insulin resistance; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TC, total cholesterol; TG, triglyceride; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; Cr, creatinine.